Internet of Events Leaderboard Traders Markets Hot Bets Surveillance Pricing

Log in Get Access

Accrue
/Home
/Manifold Markets
/Will Oncolytic Virus CF33 be a groundbreaking cancer therapy and succeed in current clinical trials?

ManifoldClosedBINARY · cpmm-1

Will Oncolytic Virus CF33 be a groundbreaking cancer therapy and succeed in current clinical trials?

Yes20%

Yes Pool

$260

No Pool

$100

Probability

20%

Volume$197

24h Volume$0

Liquidity$150

Traders6

CreatorDanny Goss

ClosesAug 14, 2023

View on Manifold →Compare Across Platforms →

Accrue© 2026

Internet of Events Leaderboard Traders Markets Hot Bets Surveillance

The Intelligence Terminal for Prediction Markets

Terms Privacy Risk Disclosure Cookies Disclaimer Acceptable Use